![Rui Yin Chu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rui Yin Chu
Corporate Officer/Principal at
DUALITY BIOTHERAPEUTICS, INC.
Profile
Rui Yin Chu currently works at Duality Biotherapeutics, Inc., as Vice President-Translational Medicine from 2023.
Dr. Chu also formerly worked at Sanofi, as Associate Director and Cogent Biosciences, Inc., as Senior Director-Translational Medicine.
Dr. Chu received his graduate degree in 1986 and doctorate degree in 1990 from Chinese Academy of Agricultural Sciences.
Rui Yin Chu active positions
| Companies | Position | Start |
|---|---|---|
| DUALITY BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 2023-07-23 |
Former positions of Rui Yin Chu
| Companies | Position | End |
|---|---|---|
| SANOFI | Corporate Officer/Principal | - |
| COGENT BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Training of Rui Yin Chu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Chinese Academy of Agricultural Sciences
 Chinese Academy of Agricultural Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duality Biotherapeutics, Inc.
 Duality Biotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-drug conjugate and therapeutics for cancer & autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Rui Yin Chu
